| |
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
| |
||||||||||||||||||||||||||||||||||
![]() |
|
|
|
|
|
|||||||||||||||||||||||||||||
![]() |
![]() |
![]() |
||||||||||||||||||||||||||||||||
|
|
Michael Tremblay,
PhD Mike has worked with the public and independent sectors and both Fortune 500 and start-up companies (pharmaceutical, biotechnology, medical device, e-health, disease management, private equity, procurement, retailers and pharmacy chains), and with corporate and public sector executives, managers, board members, elected representatives and international public servants as well as virtually every health profession. He has been involved at a policy level with the Council of Europe, World Health Organization, European Commission, European Parliament, and various national governments (e.g. UK, Hungary, Malta, France, Belgium, Netherlands, Spain and Canada) as well as Brussels-based industry groups involved with the European Commission. Having worked in a variety of roles, Mike has been afforded the opportunity to bring together a diversity of activities into a coherent body of knowledge and understanding of health systems and policy priorities.
|
|||||||||||||||||||||||||||||||||
|
ABORIGINAL
PRACTICE |
GOVERNANCE AND PLANNING |
MANAGEMENT CONSULTING |
KTA CENTRE © 2005 Kaufman, Thomas & Associates Inc. |
||||||||||||||||||||||||||||||||||
| |
||||||||||||||||||||||||||||||||||